Comstock Capital Value Fund Q2 2025 Commentary (undefined:CPCRX)

Pakin Jarerndee/iStock via Getty Images PORTFOLIO OBSERVATIONS The following positions were our largest additions to the portfolio during the quarter: Blueprint Medicines Corporation (5.3% of net assets as of June 30, 2025), is a pharmaceutical company focused on medicines for genomically defined cancers ...